Interpreting Basic Statistics

Slides:



Advertisements
Similar presentations
How to assess an abstract
Advertisements

Understanding p-values Annie Herbert Medical Statistician Research and Development Support Unit
Comparing Two Proportions (p1 vs. p2)
ADVANCED STATISTICS FOR MEDICAL STUDIES Mwarumba Mwavita, Ph.D. School of Educational Studies Research Evaluation Measurement and Statistics (REMS) Oklahoma.
KRUSKAL-WALIS ANOVA BY RANK (Nonparametric test)
Find the Joy in Stats ? ! ? Walt Senterfitt, Ph.D., PWA Los Angeles County Department of Public Health and CHAMP.
CRITICAL APPRAISAL Dr. Cristina Ana Stoian Resident Journal Club
EPIDEMIOLOGY AND BIOSTATISTICS DEPT Esimating Population Value with Hypothesis Testing.
Epidemiology in Medicine Sandra Rodriguez Internal Medicine TTUHSC.
Chapter 25 Asking and Answering Questions About the Difference Between Two Population Means: Paired Samples.
Statistics By Z S Chaudry. Why do I need to know about statistics ? Tested in AKT To understand Journal articles and research papers.
Statistics for Health Care
Today Concepts underlying inferential statistics
Review for Exam 2 Some important themes from Chapters 6-9 Chap. 6. Significance Tests Chap. 7: Comparing Two Groups Chap. 8: Contingency Tables (Categorical.
Sample Size Determination Ziad Taib March 7, 2014.
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
Are the results valid? Was the validity of the included studies appraised?
AM Recitation 2/10/11.
 Mean: true average  Median: middle number once ranked  Mode: most repetitive  Range : difference between largest and smallest.
Multiple Choice Questions for discussion
Statistics for clinical research An introductory course.
Stats Tutorial. Is My Coin Fair? Assume it is no different from others (null hypothesis) When will you no longer accept this assumption?
Amsterdam Rehabilitation Research Center | Reade Testing significance - categorical data Martin van der Esch, PhD.
DEB BYNUM, MD AUGUST 2010 Evidence Based Medicine: Review of the basics.
Basic statistics 11/09/13.
ESTIMATION. STATISTICAL INFERENCE It is the procedure where inference about a population is made on the basis of the results obtained from a sample drawn.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 17 Inferential Statistics.
Copyright © 2008 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 22 Using Inferential Statistics to Test Hypotheses.
Statistics for Health Care Biostatistics. Phases of a Full Clinical Trial Phase I – the trial takes place after the development of a therapy and is designed.
Research Skills Basic understanding of P values and Confidence limits CHE Level 5 March 2014 Sian Moss.
Statistics for nMRCGP Jo Kirkcaldy. Curriculum Condensed Knowledge Incidence and prevalence Specificity and sensitivity Positive and negative predictive.
Correlation and Regression Used when we are interested in the relationship between two variables. NOT the differences between means or medians of different.
How to Analyze Therapy in the Medical Literature (part 2)
Maximum Likelihood Estimator of Proportion Let {s 1,s 2,…,s n } be a set of independent outcomes from a Bernoulli experiment with unknown probability.
Understanding real research 4. Randomised controlled trials.
EBCP. Random vs Systemic error Random error: errors in measurement that lead to measured values being inconsistent when repeated measures are taken. Ie:
Hypothesis Testing Hypothesis Testing Topic 11. Hypothesis Testing Another way of looking at statistical inference in which we want to ask a question.
Biostatistics, statistical software VII. Non-parametric tests: Wilcoxon’s signed rank test, Mann-Whitney U-test, Kruskal- Wallis test, Spearman’ rank correlation.
Introduction to Survival Analysis Utah State University January 28, 2008 Bill Welbourn.
1 Chapter 9 Hypothesis Testing. 2 Chapter Outline  Developing Null and Alternative Hypothesis  Type I and Type II Errors  Population Mean: Known 
Educational Research Chapter 13 Inferential Statistics Gay, Mills, and Airasian 10 th Edition.
STATISTICAL ANALYSIS FOR THE MATHEMATICALLY-CHALLENGED Associate Professor Phua Kai Lit School of Medicine & Health Sciences Monash University (Sunway.
Stats Facts Mark Halloran. Diagnostic Stats Disease present Disease absent TOTALS Test positive aba+b Test negative cdc+d TOTALSa+cb+da+b+c+d.
Measuring associations between exposures and outcomes
Ch 10 – Intro To Inference 10.1: Estimating with Confidence 10.2 Tests of Significance 10.3 Making Sense of Statistical Significance 10.4 Inference as.
The exam is of 2 hours & Marks :40 The exam is of two parts ( Part I & Part II) Part I is of 20 questions. Answer any 15 questions Each question is of.
Introduction to Inference: Confidence Intervals and Hypothesis Testing Presentation 4 First Part.
Issues concerning the interpretation of statistical significance tests.
Lecture & tutorial material prepared by: Dr. Shaffi Shaikh Tutorial presented by: Dr. Rufaidah Dabbagh Dr. Nurah Al-Amro.
Compliance Original Study Design Randomised Surgical care Medical care.
Statistical significance using Confidence Intervals
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
Course: Research in Biomedicine and Health III Seminar 5: Critical assessment of evidence.
Chapter 13 Understanding research results: statistical inference.
Non-parametric Approaches The Bootstrap. Non-parametric? Non-parametric or distribution-free tests have more lax and/or different assumptions Properties:
Introduction to Biostatistics, Harvard Extension School, Fall, 2005 © Scott Evans, Ph.D.1 Contingency Tables.
PTP 560 Research Methods Week 12 Thomas Ruediger, PT.
Biostatistics Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016.
Risk Different ways of assessing it. Objectives Be able to define and calculate: Absolute risk (reduction) Relative risk (reduction) Number needed to.
2 3 انواع مطالعات توصيفي (Descriptive) تحليلي (Analytic) مداخله اي (Interventional) مشاهده اي ( Observational ) كارآزمايي باليني كارآزمايي اجتماعي كارآزمايي.
Objectives (Chapter 20) Comparing two proportions  Comparing 2 independent samples  Confidence interval for 2 proportion  Large sample method  Plus.
GP ST2 Group, 28/9/11 Tom Gamble
HelpDesk Answers Synthesizing the Evidence
An Idiots Guide to Statistics Curriculum 3.6
Confidence Intervals and p-values
NAPLEX preparation: Biostatistics
Interpreting Basic Statistics
How to assess an abstract
Basic statistics.
Medical Statistics Exam Technique and Coaching, Part 2 Richard Kay Statistical Consultant RK Statistics Ltd 22/09/2019.
Presentation transcript:

Interpreting Basic Statistics Beginners’ statistics for assessing the effectiveness of an intervention Tom Osborne, Librarian

Basic Medical Statistics Statistics which compare risks Statistics which test confidence Forest Plots Statistics which analyse clinical investigations and screening Statistics which test differences

Statistics Which Compare Risk

CER & EER Control event rate (CER) = Risk of outcome event in control group = no in the control group with event = ? total no in the control group Risk of mortality in the control group is ?% Experimental event rate (EER) = Risk of outcome event in experimental group = no in the experimental group with event = ? total no in the experimental group Risk of mortality in the statin group is ?%

Relative Risk (RR) Compares the risk of having an event between two groups RR=1 the event is equally likely in both groups RR<1 event is less likely to happen than not (i.e. the intervention reduces the chance of having the event) RR>1 event is more likely to happen than not (increases the chances of having the event) The smallest value an RR can take is 0

Relative Risk RR = EER /CER = Compares the risk of having an event between two groups RR = EER /CER = RR = EER /CER = 0.11/0.14 = 0.78 The relative risk (RR) of mortality in the pravastatin group is 0.78 (approximately three-quarters) of that in the control group.

Relative Risk/Odds Ratio

Relative Risk Reduction (RRR) The reduction in rate of the event in the treatment group relative to the control group RRR = 1 – RR = ? The relative risk was ?% lower for statin than the control group or there is a ?% reduction in risk for patients in the statin group relative to those patients in the control group. RRR = 1 – RR = 1 - 0.78 = 0.22 = 22% The relative risk was 22% lower for statin than the control group or there is a 22% reduction in risk for patients in the statin group relative to those patients in the control group.

Absolute Risk Reduction (ARR) The difference in absolute risk of a particular event between 2 groups. Also know as the risk difference. ARR = 0 no difference between the 2 groups ARR = CER – EER = ? The absolute risk of mortality was ?% lower in the statin group than in the control group or statins reduces the risk of mortality by ?% ARR = CER – EER = 14% – 11% = 3% The absolute risk of mortality was 3% lower in the statin group than in the control group or statins reduces the risk of mortality by 3%

Numbers Needed to Treat (NTT) The number of people who need to be treated in order to prevent one additional outcome of interest. NNT = 1/ARR = ? ? patients have to be treated with statin in order to avoid one additional death NNT = 1/ARR = 33 33 patients have to be treated with statin in order to avoid one additional death A very small NNT means that a favourable outcome occurs in nearly every patient who receives the treatment and in few patients in a comparison group NNTs close to 1 are theoretically possible, they are almost never found in practice Useful for comparing the effectiveness of a number of different interventions

RR vs. ARR Consider 2 RCTs of a new drug done on 2 populations at risk of a heart attack over 10 years RCT1 (n=200) High risk group: 90/100 of those not receiving the drug (control) will have a heart attack. 60/100 of those receiving the drug will have a heart attack. RCT 2 (n=200) Low risk group: 3/100 of those not receiving the drug (control) will have a heart attack. 2/100 of those receiving the drug will have a heart attack.

RR = RRR = The relative risk was ?% lower for new drug than the control group for high risk patients RR = (60/100) / (90/100) = 0.666˙ RRR = 1-RR = 1- 0.666˙ = 0.333˙ The relative risk was 33% lower for new drug than the control group for high risk patients RR = (2/100) / (3/100) = 0.666˙ The relative risk was 33% lower for new drug than the control group for low risk patients RR = RRR = The relative risk was ?% lower for new drug than the control group for low risk patients

ARR = NNT = ? patients have to be treated with statin to avoid one additional death ARR = CER – EER = (90/100) – (60/100) = 0.3 NNT = 1/ARR = 1/0.3 = 3.3 4 patients have to be treated with statin to avoid one additional death ARR = CER – EER = (3/100) – (2/100) = 0.01 NNT = 1/ARR = 1/0.01 = 100 100 patients have to be treated with statin to avoid one additional death The absolute risk of mortality was 30% lower in the new treatment group than in the placebo group. The absolute risk of mortality was 1% lower in the new treatment group than in the placebo group. Look at the baseline risk – These phenomena may be factors in the design of drug trials. For example, a drug may be tested in severely affected people in who the ARR is likely to be impressive, but is subsequently markets for use in less severely affected patients in whom the ARR will be substantially less. RRR usually remains unchanged across disease severity ARR will vary according to events rates RRR does not take into account initial baseline risk of the outcome event To be meaningful the RRR should always be viewed in context with the underlying baseline risk (incidence) of the event ARR = NNT = ? patients have to be treated with statin to avoid one additional death

Odds Ratio Expresses the odds of having an event compared with not having an event: OR=1 the event is equally likely in both groups (i.e. no difference) OR<1 event is less likely to happen than not (i.e. the treatment reduces the chance of having the event) OR>1 event is more likely to happen than not (increases the chances of having the event) The smallest value an OR can take is 0 Calculate the Odds Ratio: OR = (498/4014) ÷ (633/3869) ≈ ? The odds ratio for mortality for people taking statins compared to the control is ? Online Calculator: http://www.hutchon.net/confidor.htm 0.76

Statistics Which Test Confidence

P-values The probability (ranging from zero to one) that the results observed in a study could have occurred by chance. (Bandolier) Convention states we accept p-values of p<0.05 to be statistically significant. (Bandolier) The P value is computed from the F ratio which is computed from the ANOVA table. P value Interpretation P<0.05 The result is unlikely to be due to chance, a statistically significant result. P>0.05 The result is likely to be due to chance, not a statistically significant result. P= 0.05 the result is quite likely to be due to chance, not a statistically significant result.

Significant at Cut Off? P value P<0.05 P<0.01 P<0.001 P=0.049

Confidence Intervals What is a confidence interval? If the same trial were to be repeated many times over, the 95% CI would define the range of values within which the true population estimate would be found in 95% of occasions What can a confidence interval indicate? Whether a result is statistically significant Indication of precision Strength of the evidence Online calculator@ http://www.hutchon.net/confidor.htm

Interpreting CIs Measure of effect Interpretation of CI Binary outcome, Ratio If a CI for an RR or OR, includes 1 then we are unable to demonstrate statistically significant difference between the two groups   Continuous outcome, Mean difference If a CI for a RRR, ARR, includes 0 we are unable to demonstrate a statistically significant difference between the two groups compared

Confidence Intervals “Trials examined the effect of education programmes on improvement in lung function in asthma sufferers” Study Mean difference (95% CI) Christiansen 0.35 (-0.28-0.99) Weingarten 1.24 (0.26-2.22) Toelle 0.47 (0.18-0.75) Are educational programmes effective at increasing lung function? Which study/studies show a significant result? Which study demonstrated the strongest evidence? Yes (all answers 2 & 3 because they DON’T cross one Toelle – less breadth, doesn’t cross 0 Measure of effect Interpretation of CI Binary outcome, Ratio If a CI for an RR or OR, includes 1 then we are unable to demonstrate statistically significant difference between the two groups   Continuous outcome, Mean difference If a CI for a RRR, ARR, includes 0 we are unable to demonstrate a statistically significant difference between the two groups compared

Forest Plots

Forest Plots “Effect of probiotics on the risk of antibiotic associated diarrhoea”

The label tells you what the comparison and outcome of interest are Effect of probiotics on the risk of antibiotic associated diarrhoea Look at the title on the forest plot – i.e. the outcome under investigation The outcome is diarrhoea, ask: ‘Do we want the probiotics to increase or reduce the event. We want it to reduce the event, therefore to show that the treatment works we look for odds ratios <1 On the LHS – list of authors of the individual studies included in the systematic review/meta-analysis for the outcome under investigation

Scale measuring treatment effect. Take care when reading labels! Effect of probiotics on the risk of antibiotic associated diarrhoea

Treatment effect sizes for each study (plus 95% CI) Effect of probiotics on the risk of antibiotic associated diarrhoea The Squares represent the Odds ratios for each of the individual studies (Odds ratios also given in the column on the RHS) The size of the squares represents the weight each study is given in the Meta-analysis (also seen in last column). The larger the square the more weight the study carries in the MA (usually due to a larger sample size). Which is the largest study?

The % weight given to each study in the pooled analysis Effect of probiotics on the risk of antibiotic associated diarrhoea The size of the squares represents the weight each study is given in the Meta-analysis (also seen in last column). The larger the square the more weight the study carries in the MA (usually due to a larger sample size). Which is the largest study? Why do we weight studies? One approach to combining trials would be just to add up all the treatment groups together and control groups together and compare? Breaks the power of randomisation Imbalances within trials will introduce bias Point estimate

Horizontal lines are confidence intervals Diamond shape is pooled effect Horizontal width of diamond is confidence interval Effect of probiotics on the risk of antibiotic associated diarrhoea The horizontal lines crossing each square are the 95% Confidence intervals for the individual studies. The longer the line, the bigger the confidence interval, the less precise the study results in comparison. NB You can have lots of trials that cross the line of no effect yet when cumulative show an effect, this is because as individual trials there is no statistically significant difference but when added together the result is more powerful and stats. sig

The vertical line in middle is the line of no effect For ratios this is 1, for means this is 0 Effect of probiotics on the risk of antibiotic associated diarrhoea The line of no effect (ie where there is no difference between the treatment and comparison) is at 1 (because we are looking at CIs around Odds ratios). Therefore any study whose confidence intervals cross this line are not statistically significant and we don’t know whether the treatment works or not. Ask: Which study yielded the most precise results (Adam) and why? (Shortest CI) Ask: Which study yielded the least precise results (Lewis) and why? (longest CI)

Exercise Do the studies favour group behaviour for smoking cessation? Which study/studies show a significant result? Which study demonstrated the strongest evidence? 25

Statistics Which Analyse Clinical Investigations and Screening

Sensitivity Specificity Sensitivity:  If a person has a disease, how often will the test be positive (true positive rate)?  Put another way, if the test is highly sensitive and the test result is negative you can be nearly certain that they don’t have disease.  Specificity:  If a person does not have the disease how often will the test be negative (true negative rate)? In other terms, if the test result for a highly specific test is positive you can be nearly certain that they actually have the disease. Used to analyse the value of screening or tests

Sensitivity Specificity A Sensitive test helps rule out disease (when the result is negative). Sensitivity rule out or "Snout" Sensitivity= true positives/(true positive + false negative) A very specific test rules in disease with a high degree of confidence Specificity rule in or "Spin". Specificity=true negatives/(true negative + false positives)

SnNOut & SpPIN!!!!! A very specific test, when positive, helps rule-in disease (SpPIn). For example, if a test was 95% specific but only 70% sensitive, and 10% of patients had the disease, you get the following 2 x 2 table: 14 out of 25 patients with a positive test have the disease Disease No Disease Positive test 14 9 Negative test 6 171

SnNOut & SpPIN!!!!! A test that is very sensitive is generally very good at ruling out disease when negative. The acronym is "SnNOut". For example, consider a test which is 95% sensitive, 60% specific, with a pre-test probability of disease of 10%: Only 1 of 109 patients with a negative test has the disease in question. Disease No Disease Positive test 19 72 Negative test 1 108

Quick Quiz A very sensitive test, when negative, helps you: a: Rule-in disease b: Rule-out disease c: Confuse medical students d: Save money A test which is highly specific, when positive, helps you: B: A test that is very sensitive is generally very good at ruling out disease when negative.  The acronym is "SnNOut".  A: A very specific test, when positive, helps rule-in disease (SpPIn). 

Two-way table & Calculations Disease No Disease Positive A B (false positive) Negative C (false negative) D Sensitivity: If the patient has the disease, we need to know how often the test will be positive: This is calculated from A A + C Specificity: If the patient is in fact healthy, we want to know how often the test will be negative: This is given by: D D + B

Two-way table & Calculations Disease No Disease Positive A B (false positive) Negative C (false negative) D Positive Predictive Value: If the test result is positive, what is the likelihood that the patient will have the condition: A A + B Negative Predictive Value: If the test result is negative, what is the likelihood that the patient will be healthy: This is given by: D D + C

Exercise 100 patients were tested for haematemesis. The presence or absence of gastric cancers was diagnosed from endoscopic findings and biopsy: Present Absent Positive 20 30 Negative 5 45 Calculate the Sensitivity = If gastric cancer is present, there is ? chance of the test picking it up Calculate the Specificity = If there is no gastric cancer there is ? chance of the test being negative – but ? will have a false positive result. Calculate the PPV = There is a ? chance, if the test is positive, that the patient actually has gastric cancer. Calculate the NPV = There is a ? chance, if the test is negative, that the patient does not have gastric cancer. However, there is still a ? chance of a false negative, i.e. that the patient does have gastric cancer. Calculate the Sensitivity = If gastric cancer is present, there is 80% (0.8) chance of the test picking it up Calculate the Specificity = If there is no gastric cancer there is 60% (0.6) chance of the test being negative – but 40% (0.4) will have a false positive result. Calculate the PPV = There is a 40% (0.4) chance, if the test is positive, that the patient actually has gastric cancer. Calculate the NPV = There is a 90% (0.9) chance, if the test is negative, that the patient does not have gastric cancer. However, there is still a 10% chance of a false negative, i.e. that the patient does have gastric cancer.

Statistics Which Test Differences Much more difficult statistics!

Parametric Tests Analysis of Variance (ANOVA) t test Compares the means of two or more samples to see if whether they come from the same population. A table is created and then used to calculate f values and P-Values. t test Testing the probability that samples come from a population with the same value. Proves the study has had an effect. It's pretty much impossible to interpret the t-value without knowing the sample sizes in the study. For the overwhelming vast majority of situations, a t- value of 6.67 will be "statistically significant.” The further away from 0 the better. Use P-Values. Parametric tests are only used when data follow a ‘normal’ distribution.

Mann-Whitney U test A non-parametric statistic used when data are not normally distributed (and thus unsuitable for parametric tests). Doesn’t state the size of a difference, only the likeliness of difference. For example a study looking at the ages of two groups of triaged patients might use a Mann-Whitney U test to test the hypothesis that there’s no difference in the ages between the two groups. Very difficult to understand Statisticians ‘rank’ data and compare the ranks Go straight to the P-Value for results

Chi-Squared Usually written as X A measure of the difference between actual and expected frequencies. Difficult to interpret by itself, dependent on a number of other factors studied. Gives approximate P-Value and is inappropriate for small samples. Use the P-Value to see likelihood there is no difference between the groups. Some papers will give the “Fisher’s exact test” results instead. This is usually stronger as it gives an exact P-Value. Other non-parametric tests include: the Wilcoxon Signed-Rank Test, the Kruskal-Wallis Test, and the Friedman Test 2

Just use the P- Value And breathe…

Library outreach service The library Level 5, Education Centre Upper Maudlin St Tel. ext. 20105 Email. library@uhbristol.nhs.uk